Enanta Pharma ENTA announced its Q4 earnings on Monday, November 25, 2024 at 04:01 PM.
Here's a breakdown of the earnings report.
Earnings
Enanta Pharma beat estimated earnings by 4.0%, reporting an EPS of $-1.36 versus an estimate of $-1.41.
Revenue was down $4.33 million from the same period last year.
Performance in Previous Earnings
During the previous quarter, the company beat on EPS by $0.38, leading to a 1.0% increase share price change the next day.
Here's a look at Enanta Pharma's past performance:
Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
---|---|---|---|---|
EPS Estimate | -1.45 | -1.33 | -1.19 | -2 |
EPS Actual | -1.07 | -1.47 | -1.58 | -1.33 |
Revenue Estimate | 17.18M | 16.52M | 21.28M | 17.50M |
Revenue Actual | 17.97M | 17.05M | 18.00M | 18.93M |
To track all earnings releases for Enanta Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.